Safety and effectiveness of ruxolitinib in real-world patients with myelofibrosis: A 2-year observational study from Taiwan.
Kuo MC, Lin CC, Lin HY, Gau JP, Wang MC, Chang MC, Chen TC, Yeh SP, Chen YC, Huang CE, Chiang IJ, Cheng HW, Lee YM, Ku FC, Chang CS.
Kuo MC, et al.
Leuk Res. 2024 Dec;147:107601. doi: 10.1016/j.leukres.2024.107601. Epub 2024 Oct 23.
Leuk Res. 2024.
PMID: 39488195
No abstract available.